Although it remains speculative, our data leads us to hypothesize that endothelial cell dysfunction mediated by the antagonizing effect of AIDA on JNK contributes to inter-individual variation in CAD risk in humans. The gene discussed is AIDA; the disease is coronary artery disorder.